24. Yano S. [Clinical usefulness of bone turnover markers in the management of osteoporosis]. Rinsho Byori. 2013; 61: 852–9

25. Sakai M, Oimomi M, Kasuga M. Experimental studies on the role of fructose in the development of diabetic complications. Kobe J Med Sci. 2002; 48: 125–36

26. Schiekofer S, Andrassy M, Chen J et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes. 2003; 52: 621–33

27. Kellow NJ, Coughlan MT. Effect of diet-derived advanced glycation end products on inflammation. Nutr Rev. 2015 Sep 15. pii: nuv030. [Epub ahead of print]

28. Poulsen MW, Hedegaard RV, Andersen JM et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013; 60: 10–37

29. Van Puyvelde K, Mets T, Njemini R, Beyer I, Bautmans I. Effect of advanced glycation end product intake on inflammation and aging: a systematic review. Nutr Rev. 2014; 72: 638–50

30. Sanguineti R, Puddu A, Mach F, Montecucco F, Viviani GL. Advanced glycation end products play adverse proinflammatory activities in osteoporosis. Mediators Inflamm. 2014; 2014: 975872

31. Leinmüller R. Bisphosphonattherapie zur Frakturprophylaxe: Knochendichtemessung nach Absetzen wenig hilfreich für Prognose Dtsch Arztebl 2014; 111: A-1370

32. Barbezier N, Tessier FJ, Chango A. [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications]. Ann Biol Clin (Paris). 2014; 72: 669–80

33. Chuah YK, Basir R, Talib H, Tie TH, Nordin N. Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflam. 2013; 2013: 403460 doi: 10.1155/2013/ 403460. Epub 2013 Sep 11

34. Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014; 2: 411–29

35. Angeloni C, Zambonin L, Hrelia S.Role of methylglyoxal in Alzheimer’s disease. Biomed Res Int. 2014; 2014: 238485. doi: 10.1155/2014/238485. Epub 2014 Mar 9.

36. Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014; 18: 1–14

37. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007; 65: 147–51

38. Muti P, Bradlow HL, Micheli A et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000; 11: 635–40

39. Meilahn EN, De Stavola B, Allen DS. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer. 1998; 78: 1250–5

40. Liska DJ, Leupp LR. Estrogen metabolism: A complex web. JANA. 2002; 5: 4–14

41. Bhavnani BR. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer’s. J Steroid Biochem Mol Biol. 2003; 85: 473–82

42. Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci. 2005; 1056: 218–33

43. Thiel MJ, Schaefer CJ, Lesch ME et al. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms. Arthritis Rheum. 2007; 56: 3347–57

44. Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J Intern Med. 2004; 255: 344–50

45. Dayer JM Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin Exp Rheumatol. 2002; 20: 14–20

46. Tillu DV, Melemedjian OK, Asiedu MN. Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain. Mol Pain. 2012; 8: 5

47. Uddin MM, Emran TB, Mahib MM, Dash R. Molecular docking and analgesic studies of Erythrina variegata×s derived phytochemicals with COX enzymes. Bioinformation. 2014; 10: 630–6

48. Yang CL, Or TC, Ho MH, Lau AS. Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clin Rev Allergy Immunol. 2013; 44: 284–300

49. Divya CS, Pillai MR. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog. 2006; 45: 320–32

50. Chen SS, Michael A, Butler-Manuel SA. Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals. Discov Med. 2012; 13: 7–17

51. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin in